CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 24 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | +100.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 739,917 | $5,135,000 | 2.89% |
| JW Asset Management, LLC | 263,881 | $1,830,000 | 0.38% |
| BARD ASSOCIATES INC | 442,825 | $3,075,000 | 0.29% |
| Ariel Investments | 1,393,125 | $9,668,000 | 0.11% |
| TFS CAPITAL LLC | 11,499 | $80,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,038,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $83,000 | 0.01% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10,945 | $76,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $366,000 | 0.01% |
| Spark Investment Management LLC | 22,600 | $156,000 | 0.01% |